Skip to contentA
Aeternum Health, Inc.
A
AETNAeternum Health, Inc. Q4 2025 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$23.53K$23.53Kderived+88.5% vs Q4 2024 Net Income-$99.27K-$99.27KderivedN/M vs Q4 2024 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Aeternum Health, Inc. · CIK 764630 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$8,961N/M Operating Incomederived-$82,353N/M Operating Cash Flowderived-$38,507N/M Margins · derivedGross margin38.1%+210.6 pt vs Q4 2024
Operating margin-350.0%+630.8 pt vs Q4 2024
Net margin-421.9%+694.4 pt vs Q4 2024
ended Dec 31, 2025 · filed Mar 31, 2026 · 90 d after period end